电子虚弱指数表明血液透析末期病患者的死亡风险:使用两个来源的链接数据进行回顾性生存分析
Samuel D Relton1, Jenny Hewison1, Zoe Rogers1
1Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK.
Clinical kidney journal
|January 16, 2026
概括
电子虚弱指数 (eFI) 强烈预测开始透析的患者的生存率. 然而,初级保健和英国脏注册数据集之间的存活数据差异突出显示,在临床应用之前需要仔细分析.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 末期病 (ESKD) 患者往往具有较高的并发病率和脆弱性.
- 透析可能对某些脆弱的患者群体提供有限的益处.
- 需要预测工具来指导ESKD的治疗决策.
研究的目的:
- 评估电子虚弱指数 (eFI) 在预测开始透析的患者的存活率方面的有用性.
- 在单个脏单位人群中使用eFI建模生存时间.
- 调查eFI提供的预后生存信息.
主要方法:
- 来自英国单个脏单位的两个数据集 (2000-2019) 的回顾性生存分析.
- 分别包括599名和553名参与者.
- 计算eFI和其他生存相关共变量的危险比率.
主要成果:
- 透析开始时的虚弱度得分对随后的存活率有很大影响.
- 在数据集之间观察到的总生存和eFI生存关系的差异.
- 来自初级保健和英国脏注册数据集显示出不同的生存模式.
结论:
- 这项研究表明,eFI与透析患者的存活率有很强的关联.
- 在初级保健和英国脏注册数据之间存在重大差异.
- 对大型数据集的进一步分析对于明智的患者护理和服务规划至关重要.
相关概念视频
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
190
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
190
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Renal Failure: Dose Adjustments
438
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
438
Acute Kidney Injury I: Introduction
581
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
581
Chronic Kidney Disease I: Introduction
573
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
573
Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344


